VivoSeq
Other

Glucocorticoids

0

Pipeline Programs↗

3

Active Trials↗

3

Companies Involved↗

Glucocorticoids is an early-stage landscape with 0 programs across 3 companies. The most active players are Sanofi, Roche, Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Sanofi logo

Sanofi

0 programs

PreclinicalRoche logo

Roche

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

28

clinical trials

Completed15 · 54%
Unknown status5 · 18%
Terminated3 · 11%
Not yet recruiting2 · 7%
Active, not recruiting1 · 4%
Withdrawn1 · 4%
Other1 · 4%

Clinical Trials

Trial Activity

28 trials

A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies
Active, not recruiting·Sanofi logoSanofi·Phase 4·NCT06616415·6 enrolled
Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP
Not yet recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 4·NCT07189910·150 enrolled
Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD
Not yet recruiting·TTianjin Medical University General Hospital·Phase 3·NCT07132398·170 enrolled
Glucocorticoids and Skin Healing in Diabetes (GC-SHealD)
Completed·UUniversity of Leeds·Phase 2·NCT03313297·28 enrolled
Glucocorticoids and Bone in Graves' Ophthalmopathy
Completed·—·N/A·NCT03122847·39 enrolled
Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids
Completed·VVanderbilt University Medical Center·Phase 1·NCT03023891·25 enrolled
Extinction of Fear Memories With Glucocorticoids in Veterans With PTSD
Completed·VVA Office of Research and Development·N/A·NCT01090180·129 enrolled
Oral Glucocorticoids Effect on Post Endodontic Pain
Completed·—·Phase 4·NCT02819648·400 enrolled
Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger
Completed·YYale University·Phase 1·NCT02722200·28 enrolled
A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice
Completed·Roche logoRoche·N/A·NCT03291457·101 enrolled
Short Term Effect of Glucocorticoids on Brown Adipose Tissue Thermogenesis in Humans
Completed·UUniversity Hospital, Basel, Switzerland·Phase 4·NCT03269747·16 enrolled
Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Glucocorticoid Treatment for No-Reflow in STEMI
Completed·Amosov National Institute of Cardiovascular Surgery·Phase 2·NCT06552442·10 enrolled
Effect of Peri-operative Glucocorticoids on Short-term Functional Outcome After THA
Completed·UUniversitaire Ziekenhuizen KU Leuven·N/A·NCT04317872·71 enrolled
Pharmacokinetics of Glucocorticoids in Children (GLUCOPED)
Completed·AAssistance Publique - Hôpitaux de Paris·N/A·NCT02252237·146 enrolled
The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)
Completed·—·Phase 1·NCT05919992·24 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)